LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 657 participants.

Also called NCT01628159

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 657 participants (enrolled count) (from the registry)
Sponsor
  • C. R. Bard Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01628159
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Belgium, Germany, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01628159. Allocation not applicable; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2018-09 (actual). Results posted on 2020-04-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)
Condition
Peripheral Artery Disease
Intervention (Device)
Lutonix Drug Coated Balloon
Lead sponsor
C. R. Bard (class: industry)

Record details

Record id
cardio:ct-nct01628159
Content hash
2d0b2ec3aa354fe8c7acb0447d12504d2c62b448c89788c0a86264e957f64641